ERG(C12A8),RMab
About 50% of prostate cancers have gene fusion mutations. TMPRSS2:ERG is the most common fusion gene, which is closely related to the invasiveness and prognosis of prostate cancer. ERG-positive cases often have a higher prostate cancer stage, a high recurrence rate, and pelvic lymph node metastasis.
Intended Use
About 50% of prostate cancers have gene fusion mutations. TMPRSS2:ERG is the most common fusion gene, which is closely related to the invasiveness and prognosis of prostate cancer. ERG-positive cases often have a higher prostate cancer stage, a high recurrence rate, and pelvic lymph node metastasis.
[Storage and Validity]
Store at 2~8°C. Avoid freezing.
Maintain temperature below room temperature during transport, ensuring it does not exceed one week.
Specification
Product Name | ERG(C12A8),RMab |
Clone | C12A8 |
Catalog No. | CER-0071 |
Positive Site | Nucleus |
Applicable Tissue | Paraffin section |
Pre-treatment | Heat retrieval |
Format and Volume | Ready-to-use: 1mL, 3mL, 6mL |
Download
-
Intended Use
-
Specification
